ACXP - CIK 0001736243
The table below shows Acurx Pharmaceuticals, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment |
| - |
| - |
| - |
| - |
| - |
| Goodwill | - | - | - | - | - |
| Total assets | $7.69M | $3.86M | $7.71M | $9.38M | $13.25M |
| Accounts payable | - | - | - | - | - |
| Total current liabilities | $2.42M | $3.24M | $3.04M | $2.06M | $843.91K |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $2.42M | $3.24M | $3.04M | $2.06M | $843.91K |
| Retained earnings | -$75.29M | -$67.32M | -$53.22M | -$38.64M | -$26.55M |
| Total equity | $5.27M | $615.12K | $4.67M | $7.32M | - |